Reducing Blood Pressure in Patients With High Cardiovascular Risk in the Safety-Net — BP-REACH  

Stroke Clinical Trial

Official title: BP-REACH: Blood Pressure Disparities Reduction, Equity, and Access Among Safety Net Patients With Cardiovascular Health Risk

Status Recruiting

Clinical Trial Summary

BP-REACH is a study of a team-based (pharmacist and health coach) program for lowering blood pressure for people with a prior stroke or heart attack in the Los Angeles Department of Health Services public healthcare system.

The goal of this clinical trial is to test if this team based program is better at helping people reduce their blood pressure than usual care for people with prior heart attack or stroke. The main questions it aims to answer are:

• Do people in the REACH BP program have lower blood pressure at 12 months compared to those getting usual care?

• Do people in the REACH BP program have better Life's Essential 8 scores and patient experience compared to those getting usual care?

Clinical Trial Description

Hypertension is the leading contributor to preventable death and a major risk factor for recurrent cardiovascular events. To enhance BP control after stroke or myocardial infarction (MI), multilevel interventions are needed that incorporate health system, patient, and community level factors.

BP-REACH aims to test the impact of an intervention on systolic blood pressure (SBP) for individuals with a history of stroke or MI in a randomized controlled trial in the Los Angeles Department of Health Services public healthcare system. The primary outcome will be change in systolic blood pressure (SBP) at 12 months.

Hypothesis: Patients randomized to the intervention will achieve >2.4 mm Hg greater reduction in SBP at 1 year versus those randomized to usual care.

The study population will include participants from the inpatient and outpatient settings in Los Angeles County Department of Health Services health centers. The participants will be randomized in a 1:1 fashion to usual care or intervention, stratified by site, language and cardiovascular event (myocardial infarction, stroke). Outcomes will be collected from all participants at Baseline, 3 month and 12 month timepoints. The primary outcome is SBP.

Participants randomized to the intervention arm will receive additional a home blood pressure monitor, monthly phone calls from a health coach, and medication initiation and titration by a clinical pharmacist. The pharmacist will follow Los Angeles County Department of Health Services expected practices, which align with the ACC/AHA guidelines for blood pressure control and AHA guidelines for Secondary Stroke Prevention. ;

Related Conditions & MeSH terms

• Hypertension
• Infarction
• Myocardial Infarction
• Stroke

• NCT number: NCT05937685
• Study type: Interventional
• Source: University of Southern California
• Contact: Monica Ayala-Rivera
• Phone: (323) 442-0934
• Email: ayalariv@usc.edu
• Status: Recruiting
• Phase: N/A
• Start date: September 1, 2023
• Completion date: June 2026